InsidersTradesSigma
Follow the Semnur Pharmaceuticals, Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €191.1m. The latest transaction was filed on 25 September 2025 (Cession). Among the most active insiders: Scilex Holding Co. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Semnur Pharmaceuticals, Inc. es una empresa centrada en el desarrollo de tratamientos para el dolor y los trastornos neurológicos. Cotiza en NASDAQ bajo el ticker XNAS.